Title: Gemini restores normal innate immune response in CKD patients Presenter: Robin Marsden, Senior Vice President of Biology, Revelation Biosciences Date/Time: Sunday, March 29, 2026 5:30 p.m.

Dr. Vink’s appointment follows the retirement of Claude Allary from the Board of Directors. Mr. Allary has served as a director since 2014 and helped support Arch evolve into becoming a leading kidney ...

Laser gum surgery offers a minimally invasive alternative to traditional scalpel-based procedures, significantly reducing ...

Presentation to Include Additional Positive Data from the Recently Completed PRIME Clinical Study - SAN DIEGO, CA / ACCESS Newswire / January 14, 2026 / Revelation Biosciences Inc. (NASDAQ:REVB) (the ...

The Detroit Tigers finished with an 87-75 record in the third year of Scott Harris and fifth year of A.J. Hinch, placing ...

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation – a ...

Nonetheless, the authors concluded, “Liver biopsy is considered the gold standard for diagnosing MASH and MASLD. While ...

CBeyondTM Phase 2a 26-week extension data update and interim results expected Q1 2026. CBeyond Phase 2a Data Monitoring ...

When the cell's recycling stations, the lysosomes, start leaking, it can become dangerous. Toxic waste risks spreading and ...

This clinical-stage biotech focused on long-acting antibody therapies reported a notable insider sale amid ongoing pipeline ...

SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...

Trust us—you know a guy or two who’s had this procedure, even if they won’t admit it. Here's what they know that you don’t.